Several treatment schemes have been applied clinically, such as intraocular injection of anti-vascular endothelial growth factor (VEGF) agents for DME, laser photocoagulation for PDR, and vitrectomy for vitreous hemorrhage and tractional retinal detachment. The gene discussed is VEGFA; the disease is vitreous hemorrhage.